OSR Holdings signs term sheet for VXM01 license with up to $815 million milestones
OSR Holdings, Inc.
OSR Holdings, Inc. OSRH | 0.00 |
- OSR Holdings, via unit Vaximm, signed binding term sheet on March 27, 2026 with BCM Europe for revised global exclusive license deal for VXM01.
- Revised structure makes OSR direct counterparty, positioning it as primary recipient of milestone and royalty payments.
- BCM Europe would receive exclusive worldwide sublicensable rights to develop and commercialize VXM01 under definitive agreement.
- Milestone payments could total up to $815 million, payable directly to OSR.
- OSR would provide Vaximm development financing facility of up to $30 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-039278), on April 02, 2026, and is solely responsible for the information contained therein.
